PIM3, a serine/threonine kinase, was demonstrated to phosphorylate and inhibit proteins important in promoting CRC cell apoptosis, and inhibition of PIM3 with miR-33a mitigated the effect of cholesterol on CRC cells. Here, MARK2 is linked to colorectal carcinoma.